SCHEMBL9739706

SCHEMBL9739706

CCCCc1ncc(C(=O)OCC)c(=O)[nH]1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.60
▸ GAA P10253 2/20 0.60
▸ KDM4E B2RXH2 5/20 0.51
▸ L3MBTL1 Q9Y468 4/20 0.51
▸ MAPT P10636 3/20 0.51
▸ POLB P06746 3/20 0.51
▸ TDP1 Q9NUW8 1/20 0.51
▸ LMNA P02545 3/20 0.49
▸ CA12 O43570 2/20 0.46
▸ CA1 P00915 2/20 0.46
▸ CA2 P00918 2/20 0.46
▸ CA6 P23280 2/20 0.46
▸ CA7 P43166 2/20 0.46
▸ CA13 Q8N1Q1 2/20 0.46
▸ HSP90AA1 P07900 1/20 0.46
▸ NPC1 O15118 2/20 0.46
▸ KDM6B O15054 2/20 0.45
▸ KDM4A O75164 2/20 0.45
▸ KDM4D Q6B0I6 2/20 0.45
▸ KDM3B Q7LBC6 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9127016 0.87 GAA (0.49) ALDH1A1GAAKDM4EL3MBTL1MAPT
SCHEMBL2902593 0.85 ALDH1A1 (0.66) ALDH1A1GAAKDM4EL3MBTL1MAPT
SCHEMBL6706506 0.83 GAA (0.63) ALDH1A1GAAKDM4EL3MBTL1MAPT
SCHEMBL23900636 0.83 ALDH1A1 (0.63) ALDH1A1GAAKDM4EL3MBTL1MAPT
SCHEMBL27454468 0.81 MMP2 (0.48) ALDH1A1GAAKDM4EMAPTLMNA
SCHEMBL1014580 0.79 KDM4E (0.58) ALDH1A1GAAKDM4EL3MBTL1MAPT
SCHEMBL2898616 0.77 GAA (0.56) ALDH1A1GAAKDM4EL3MBTL1MAPT
SCHEMBL7997265 0.77 KDM4E (0.55) ALDH1A1GAAKDM4EL3MBTL1MAPT
SCHEMBL18585976 0.77 ALDH1A1 (0.59) ALDH1A1GAAKDM4EL3MBTL1MAPT
SCHEMBL3824059 0.75 GAA (0.54) ALDH1A1GAAKDM4EL3MBTL1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5100897-A Hypotensive agents, congestive heart failure, ocular hypertension MERCK & CO., INC. (US) 1992-03-31 — — US disclosed
EP-0419048-A2 Substituted pyrimidinones as angiotensin II antagonists MERCK & CO. INC. (US) 1991-03-27 — — EP disclosed
Send feedback